RIVERVIEW, MI — (Marketwired) — 06/11/13 — Ash Stevens, Inc. (ASI), a leading provider of global contract pharmaceutical drug substance development and API (Active Pharmaceutical Ingredient) manufacturing services, announces the U.S. Food and Drug Administration (FDA) has approved ASI-s manufacturing facility in Riverview, Michigan for the manufacture of the API in ARIAD Pharmaceuticals, Inc.-s (NASDAQ: ARIA) recently approved oncology drug Iclusig® (ponatinib). The drug was granted acce
